Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%

Jubilant Pharmova reported 19% revenue growth in Q4FY26, but weaker margins dragged profit lower. Shares turned volatile after earnings, while the company also announced a final dividend of ₹5 per share.

Leave a Reply

Your email address will not be published. Required fields are marked *